TIAA CREF Investment Management LLC Has $1.34 Million Position in Natera, Inc. (NTRA)

TIAA CREF Investment Management LLC increased its position in shares of Natera, Inc. (NASDAQ:NTRA) by 31.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 123,534 shares of the medical research company’s stock after acquiring an additional 29,633 shares during the period. TIAA CREF Investment Management LLC owned approximately 0.23% of Natera worth $1,342,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of NTRA. Prudential Financial Inc. increased its holdings in Natera by 185.9% during the 1st quarter. Prudential Financial Inc. now owns 73,820 shares of the medical research company’s stock worth $654,000 after acquiring an additional 48,000 shares during the period. American International Group Inc. increased its holdings in Natera by 7.1% during the 1st quarter. American International Group Inc. now owns 16,065 shares of the medical research company’s stock worth $142,000 after acquiring an additional 1,068 shares during the period. Alliancebernstein L.P. increased its holdings in Natera by 5.6% during the 1st quarter. Alliancebernstein L.P. now owns 26,600 shares of the medical research company’s stock worth $236,000 after acquiring an additional 1,400 shares during the period. Principal Financial Group Inc. increased its holdings in Natera by 0.6% during the 1st quarter. Principal Financial Group Inc. now owns 111,278 shares of the medical research company’s stock worth $987,000 after acquiring an additional 688 shares during the period. Finally, Vanguard Group Inc. increased its holdings in Natera by 4.4% during the 1st quarter. Vanguard Group Inc. now owns 2,007,708 shares of the medical research company’s stock worth $17,808,000 after acquiring an additional 84,144 shares during the period. 59.89% of the stock is currently owned by institutional investors and hedge funds.

A number of equities analysts have recently commented on the stock. Zacks Investment Research raised shares of Natera from a “sell” rating to a “buy” rating and set a $9.25 price target on the stock in a report on Thursday, August 10th. ValuEngine raised shares of Natera from a “strong sell” rating to a “sell” rating in a report on Thursday, August 10th. Robert W. Baird reissued a “buy” rating on shares of Natera in a report on Tuesday, October 24th. Morgan Stanley decreased their price target on shares of Natera from $18.00 to $13.00 and set an “overweight” rating on the stock in a report on Monday, August 7th. Finally, Cowen and Company reissued a “buy” rating and issued a $14.00 price target on shares of Natera in a report on Friday, September 1st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company’s stock. Natera currently has an average rating of “Buy” and a consensus price target of $16.20.

ILLEGAL ACTIVITY WARNING: “TIAA CREF Investment Management LLC Has $1.34 Million Position in Natera, Inc. (NTRA)” was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://sportsperspectives.com/2017/11/07/tiaa-cref-investment-management-llc-has-1-34-million-position-in-natera-inc-ntra.html.

Natera, Inc. (NASDAQ NTRA) opened at $10.97 on Tuesday.

Natera (NASDAQ:NTRA) last issued its quarterly earnings results on Tuesday, August 8th. The medical research company reported ($0.52) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.52). The firm had revenue of $53.60 million for the quarter, compared to analyst estimates of $50.57 million. Natera had a negative net margin of 62.64% and a negative return on equity of 137.46%. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.46) EPS. analysts predict that Natera, Inc. will post -2.02 EPS for the current year.

In other news, insider Jonathan Sheena sold 120,000 shares of the company’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $12.54, for a total value of $1,504,800.00. Following the completion of the sale, the insider now owns 533,208 shares of the company’s stock, valued at approximately $6,686,428.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 12.57% of the stock is owned by corporate insiders.

Natera Profile

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply